Health - Diabetes latest news

Diamyd Medical reports that the world's most influential medical journal, the New England Journal of medicine, has published an article with results from the company's study of the Diamyd(R) diabetes vaccine for type 1 diabetes. The article is now available on the journal's web site (http://www.nejm.org) and will be in print on October 30.

Takeda Pharmaceutical Company Limited ("Takeda") today announced that Takeda Global Research and Development Center, Inc., a wholly owned United States (U.S.) subsidiary, received notification that the U.S. Food and Drug Administration (FDA) will not be able to complete its review of the alogliptin New Drug Application (NDA) by the Prescription Drug User Fee Act (PDUFA) date of October 27, 2008.

MyCareTeam has announced that through a relationship with The Barton Center for diabetes Education that its popular diabetes management software product, MCT-Diabetes, will be used extensively going forward with the management of its campers at the Barton Camp in Oxford, MA and the Joslin Camp in Charlton, MA.

Research and Markets has announced the addition of the "Forecast Insight: Antidiabetics - Switching to New Molecule Antidiabetics Drives Market Growth" report to their offering. The antidiabetics market is expected to reach $29 billion, across the seven major markets, by 2017.

HealthDay - FRIDAY, Oct. 10 (HealthDay News) -- patients coping with metabolic syndrome have a 75 percent higher risk for developing colorectal cancer sometime in their lives, a new study suggests.

Title: Small Intestine Senses Bitter Toxins in FoodCategory: health newscreated: 10/10/2008 2:00:00 amlast Editorial review: 10/10/2008